Mesenchymal stem cell-derived secretomes for therapeutic potential of premature infant diseases

© 2020 The Author(s)..

Preterm birth is a complex syndrome and remains a substantial public health problem globally. Its common complications include periventricular leukomalacia (PVL), bronchopulmonary dysplasia (BPD), necrotizing enterocolitis (NEC) and retinopathy of prematurity (ROP). Despite great advances in the comprehension of the pathogenesis and improvements in neonatal intensive care and associated medicine, preterm birth-related diseases remain essentially without adequate treatment and can lead to high morbidity and mortality. The therapeutic potential of mesenchymal stem/stromal cells (MSCs) appears promising as evidenced by their efficacy in preclinical models of pathologies relevant to premature infant complications. MSC-based therapeutic efficacy is closely associated with MSC secretomes and a subsequent paracrine action response to tissue injuries, which are complex and abundant in response to the local microenvironment. In the current review, we summarize the paracrine mechanisms of MSC secretomes underlying diverse preterm birth-related diseases, including PVL, BPD, NEC and ROP, are summarized, and focus is placed on MSC-conditioned media (CM) and MSC-derived extracellular vesicles (EVs) as key mediators of modulatory action, thereby providing new insights for future therapies in newborn medicine.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:40

Enthalten in:

Bioscience reports - 40(2020), 5 vom: 29. Mai

Sprache:

Englisch

Beteiligte Personen:

Wang, Yu [VerfasserIn]
Long, Wei [VerfasserIn]
Cao, Yan [VerfasserIn]
Li, Jingyun [VerfasserIn]
You, Lianghui [VerfasserIn]
Fan, Yuru [VerfasserIn]

Links:

Volltext

Themen:

Culture Media, Conditioned
Extracellular vesicles
Journal Article
Mesenchymal stem/stromal cells
Premature infant disease
Research Support, Non-U.S. Gov't
Review
Secretome

Anmerkungen:

Date Completed 23.03.2021

Date Revised 27.03.2021

published: Print

Citation Status MEDLINE

doi:

10.1042/BSR20200241

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM309044529